StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
JHS.BO$8.90+0.91%
Fair $8.90+0.0%

JHS.BO

JHS Svendgaard Laboratories Limited

Consumer Defensive / Household & Personal ProductsBSE

$8.90

+0.08 (+0.91%)

Fairly Valued+0.0%Fair Value $8.90Fund rank 30/100 · Data gapFallback financials|
SA 17/F
F-Score: 2/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 20%

FCF escenarios

weak_data · normalized FCF $-157.1M · quality 55.3/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 22/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

17/100

F

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -11.4%, below the 5% threshold
Thesis & Journal · JHS.BOLocal privado en este navegador · JHS Svendgaard Laboratories Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$778M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-11.4%

↓

Gross Margin

25.4%

↓

Debt/Equity

0.04

↓
52-Week Range$9
$6$15

TradingView lightweight chart

JHS.BO price, volumen y niveles de valoración

Último $8.900Periodo -82.6%
Fair value: $8.900

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+2.2%

FCF CAGR

—

FCF margin

-17.2%

FCF / Net income

0.80x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $912.6M · net income $-197.4M · FCF $-157.1M

2022-FY → 2025-FY

Gross margin

25.4%+1.8% pts

Operating margin

-10.5%-4.6% pts

Net margin

-21.6%-16.9% pts

FCF margin

-17.2%+1.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$912.6M$912.6M$698.1M$840.8M$854.9M
Net Income$-197.4M$-197.4M$-40.6M$-175.2M$-40.5M
EBITDA$-40.9M$-40.9M$33.4M$-164.3M$84.2M
EPS-2.37-2.37-0.52-2.23-0.63
Gross Margin25.4%25.4%29.2%19.7%23.6%
Operating Margin-10.5%-10.5%-9.0%-17.4%-5.9%
Net Margin-21.6%-21.6%-5.8%-20.8%-4.7%
Balance Sheet
Debt/Equity0.040.040.030.090.03
Current Ratio2.392.39———
Cash Flow
Free Cash Flow$-157.1M$-157.1M$-407.1M$89.4M$-158.7M
Returns
ROE-11.4%-11.4%-2.4%-10.1%-2.2%
Valuation
EV/EBITDA——45.89—19.89
P/B0.430.430.900.720.90
Growth & Yield
Revenue Growth30.7%30.7%-17.0%-1.6%—
EPS Growth-355.8%-355.8%76.7%-254.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -38.6%

Total return

-38.6%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.52 → -2.37

Residual

-38.6%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-38.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.